IMMUNEX CORP /DE/
10-Q, EX-27, 2000-08-11
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: IMMUNEX CORP /DE/, 10-Q, EX-10.2, 2000-08-11
Next: NTS PROPERTIES IV, 10-Q, 2000-08-11



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the
consolidated balance sheet as of June 30, 2000 and the consolidated statement of
operations for the six-month period ended June 30, 2000 and is qualified in its
entirety by reference to such financial statements.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                         151,377
<SECURITIES>                                   598,627
<RECEIVABLES>                                   60,119
<ALLOWANCES>                                     1,245
<INVENTORY>                                     19,029
<CURRENT-ASSETS>                               867,521
<PP&E>                                         228,419
<DEPRECIATION>                                  87,646
<TOTAL-ASSETS>                               1,114,072
<CURRENT-LIABILITIES>                          151,499
<BONDS>                                        450,000
                                0
                                          0
<COMMON>                                       845,940
<OTHER-SE>                                   (334,203)
<TOTAL-LIABILITY-AND-EQUITY>                 1,114,072
<SALES>                                        362,894
<TOTAL-REVENUES>                               392,188
<CGS>                                          104,832
<TOTAL-COSTS>                                  334,967
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                   485
<INTEREST-EXPENSE>                               6,873
<INCOME-PRETAX>                                 74,388
<INCOME-TAX>                                       714
<INCOME-CONTINUING>                             73,674
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    73,674
<EPS-BASIC>                                       0.15
<EPS-DILUTED>                                     0.14


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission